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Summary
Identification of the causative pathogen(s) of pneumonia would allow the selection of effective antibiotics and thus reduce the mortality rate and the emergence of drug-resistant pathogens. To identify such pathogens and to obtain these benefits, it is necessary that a clinical test is
Introduction
Pneumonia is a significant cause of morbidity and mortality in clinical settings. Clinical tests involving smear and culture of sputum, antigen tests, and paired antibody titers often fail to identify the causative pathogen(s) of pneumonia. The rapid identification of the causative pathogen(s) would allow for the selection of targeted antibiotics. Accordingly, timely identification has been shown to reduce the mortality rate and the emergence of drugresistant pathogens [1, 2] . To identify such pathogens and thus obtain the desired benefits, a clinical test is required that is rapid, accurate, easily performed, and costeffective.
In a previous study, we proposed the "battlefield hypothesis", which postulated that the organism-to-human cell number ratio may be an index for the pathogenic role of the organism [3] . The ratio was determined using a realtime PCR-based approach and used to evaluate a major commensal organism, Streptococcus pneumoniae (S. pneumoniae), with the results supporting our battlefield hypothesis. We devised a PCR-based test of sputum samples that can differentiate pathogens that are the likely causative pathogens of pneumonia from commensal organisms. Combining the described PCR system for commensal organisms with PCR detection system for foreign organisms constitute the HIRA-TAN (human cell-controlled identification of the respiratory agent from "TAN", which means sputum in Japanese) ( Table 1) .
Currently PCR-based approaches are mainly used to identify foreign organisms in respiratory specimens [4e6] . Even if such clinical tests have a multiplex detection system, identification of foreign organisms alone shows limited clinical value. In the current study, we have expanded the scope and utility of this approach by optimizing newly developed primers and cutoff values. We also focused on the detection of additional target organisms with a larger number of patient samples and broader coverage of the relevant microorganisms. We describe the ability of the procedure to identify commensal organisms and the overall performance of the HIRA-TAN system.
Materials and methods

Patients
Patients were eligible if they met the following criteria: (1) Clinical symptoms suggestive of pneumonia: cough, fever (>38.5 C), sputum production, chest discomfort/pain, or dyspnea. (2) Newly developed pulmonary infiltrates in chest radiological examination. A diagnosis of pneumonia was clinically made when patients presented with both (1) and (2) (Table 2) .
Samples
Sputum, induced sputum, or sputum obtained by intra-tracheal aspiration (sputum hereafter) was collected from patients with pneumonia. Samples were mixed well by pipetting, and divided into 2; one was submitted for a bacteriological test, and the other was submitted for HIRA-TAN based analysis. To select purulent sputum, samples with M2eP3 appearance as well as a Ct human <27 (the human-specific gene with Ct (threshold cycle) value by the real-time PCR) were studied [3] . Classification of the gross appearance of the sputum (M1, M2, P1, P2, and P3) was according to Miller and Jones.
DNA preparation
The sputum was diluted with an equal volume of phosphate-buffered saline and homogenized by vortexing. A portion of the homogenate (200 mL) was taken and mixed with AL buffer (200 mL; Qiagen, Tokyo, Japan) containing >12 mAU of proteinase K, and the resultant mixture was incubated at 56 C for 1 h. DNA was isolated into 100 mL of TE buffer with the QIAamp DNA Blood Mini Kit (Qiagen).
Pathogens
Commensal organism Commensal organisms form part of human normal flora in the respiratory system. However, in specific situations as when the host defense is weakened, the number of organisms grows beyond their typical ranges, and then pneumonia occurs. Commensal organisms cause more than half of pneumonias. Since the majority of them reside in the respiratory tract, when they are detected from respiratory sample, there is no unequivocal criterion to discriminate causative pathogen from colonizing one by the sputum examination (e.g., S. pneumoniae, Haemophilus influenzae (H. influenzae) or Pseudomonas aeruginosa (P. aeruginosa)).
Foreign organism (non-commensal organism) Foreign organisms are the cause of less than half of pneumonias. They do not reside in the respiratory tract of healthy individuals, and thus their detection indicates that they are the causative pathogens (e.g., Mycoplasma pneumoniae, L. pneumophila or Mycobacterium tuberculosis).
Criteria for commensal organisms to be the likely causative pathogen A commensal organism that fulfilled at least 1 of the following 3 criteria was considered to be a likely b The PCR reaction for K. pneumoniae only has need of starting at 95 C for 30 s followed by 40 cycles of 95 C for 10 s, 61 C for 35 s, and 72 C for 25 s. c Since Pneumocystis jiroveci was not normally identified from the healthy individuals, it was classed together as foreign organism. d Methicillin-resistant Staphylococcus aureus (MRSA) was judged as therapeutic target in HIRA-TAN both when S. aureus (femB gene) was detected above À7 in the DCt S. aureus cutoff and when DRRG (mecA gene) was also detected above À8 in the DCt MRSA cutoff altogether.
e 5 IMP producing P. aeruginosa was judged as therapeutic target in HIRA-TAN both when P. aeruginosa was detected above À6 in the DCt P. aeruginosa cutoff and IMP gene was detected altogether.
causative pathogen when: (1) an organism was identified from the normally sterile site (blood or pleural effusion); (2) a morphologically compatible organism, coexisting with abundant neutrophils, was observed through Gram staining later confirmed by sputum culture; or (3) for S. pneumoniae only: the urine antigen test was positive.
Criteria for foreign organisms to be the causative pathogen Foreign organisms that fulfilled at least 1 of the following 2 criteria was considered to be a causative pathogen when: (1) an organism was identified by culture, antigen test (involving serum, urine or nasopharyngeal specimen) or PCR test; or (2) paired serological test revealed a significant increase in antibody titer (more than four times).
Criteria for commensal organisms to be the therapeutic target by HIRA-TAN We developed the HIRA-TAN: a real-time PCR-based test for sputum that was established in simultaneous multipathogen detection as previously described [3] . The cutoff value was determined for each commensal organism, which enabled us to discriminate the bona fide therapeutic target from other commensal organisms detected by real-time PCR. With the assumption being that the high relative levels of any of the given candidate pathogens would increase its likelihood of being the causative pathogen. Here we expanded the number of PCR reactions to 23 with organism specific target genes for quantifying 7 commensal organisms, 13 foreign organisms, 2 drug resistance-related genes (DRRG), and the human-specific gene (as internal control) in the HIRA-TAN (Table 1) . Compared with our previous study here we used newly 
Registration number
The study had been registered to the University Hospital Medical Information Network (UMIN) registry before its initiation (UMIN000001694) and approved by the Saitama Medical University Hospital IRB committee (08-063) designed primer pairs and cutoff value for each target (Suppl Table 1 ).
Real-time PCR reaction
A database search was used to select potential DNA sequences to identify microorganisms of interest. The primers and probes were validated using genomic DNA from the microorganism of interest as well as screened against 74 other microorganisms (Suppl Table 1 ). The final solution of PCR reaction (25.0 mL) contained 12.5 mL TAKARA Premix Ex Taq (Takara Bio Inc., Shiga, Japan), primers (300 nM), fluorescence-labeled detection probes (100 nMe300 nM; TaqMan probe), 1.0 mL purified DNA and deionized distilled water up to 25.0 mL. The PCR reactions for 23 target genes were multiplexed in 16 reactions and amplified using in a single assay using the SmartCycler II (Cepheid, Sunnyvale, CA). The PCR was performed by starting at 95 C for 30 s followed by 40 cycles of 95 C for 8 s, 61 C for 25 s, and 72 C for 20 s.
Statistical analysis
The 95% confidence interval (CI) was calculated using the formula for the binomial probabilities by the software Mathematica Ver.8ä (Wolfram Research, IL, USA) [13] .
Ethical consideration
The research protocol for the current study was approved by the institutional review boards of the Saitama Medical University Hospital, Saitama Medical University
International Medical Center, Kan-etsu Hospital, Saitama Social Insurance Hospital, Tsurugashima Ikenodai Hospital, Kesennuma City Hospital and Ohno clinic ( Table 2) .
Observatory study registration
The prospective observatory study described in the current report had been registered to the University Hospital Medical Information Network (UMIN) registry before its initiation, where the UMIN is a registry approved by the International Committee of Medical Journal Editors (ICMJE). The UMIN registry number was UMIN000001694: A multicenter prospective study for the investigation of the validity of the cutoff values established for the HIRA-TAN system (February 06, 2009).
Results
Determination of the DCt pathogen cutoff
We confirmed that the primers and probes were specific to 7 representative commensal organisms (S. pneumoniae, H. influenzae, Moraxella catarrhalis (M. catarrhalis), P. aeruginosa, Klebsiella pneumoniae (K. pneumoniae), Escherichia coli (E. coli), and Methicillin-resistant Staphylococcus aureus (MRSA)) and the human genome, and were able to quantify their cell numbers by counting the copy numbers (Ct value) for each in sputum. The pathogen to human cell number ratio was described as the DCt pathogen value [À(Ct pathogen ÀCt human )] using 533 sputum samples collected in the past clinical study between May 2007 to January 2009. Using the microbiological examination as a reference (see Materials and Methods), we determined the smallest Figure 1 Determination ofDCt pathogen cutoff. The DCt pathogen was measured for 7 representative commensal organisms from the past clinical study (n Z 533; from May 2007 to January 2009). Samples from patients with pneumonia in which a likely causative pathogen was identified using criteria (1)e(3) (see Materials and Methods) are shown as blue circles. The DCt pathogen cutoff (a red line) was defined as the smallest DCt pathogen for the blue circles. The pathogen to human cell ratio grows wider as the DCt pathogen becomes large on the Y-axis. The theoretical concept for the cutoff value was described in greater detail in [3] . The DCt pathogen cutoff was defined below: (A) À1 for H. influenzae; (B) À4 for P. aeruginosa; (C) À6 for K. pneumoniae; (D) 0 for M. catarrhalis; (E) À7 for E. coli; (F) À8 for MRSA and (G) À6 for S. pneumoniae. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
DCt pathogen value to be the DCt pathogen cutoff to discriminate the therapeutic target: À1 in the DCt H. influenzae cutoff; À4 in the DCt P. aeruginosa cutoff; À6 in the DCt K. pneumoniae cutoff; 0 in the DCt M.catarrhalis cutoff; À7 in the DCt E. coli cutoff; À8 in the DCt MRSA cutoff and À6 in the DCt S.pneumoniae cutoff, respectively (Fig. 1) .
Prospective study
We designed a prospective study to investigate the validity of the new cutoff values for the commensal organisms in the HIRA-TAN system (Table 2: UMIN000001694) . The primary endpoint of the study was the proportion of samples in which DCt H. influenzae or DCt P. aeruginosa were greater than the cutoff value, compared to the proportion of the samples in which H. influenzae or P. aeruginosa were shown to be the likely causative pathogen. Thus the endpoint was to investigate DCt H. influenzae cutoff or DCt P. aeruginosa cutoff to classify H. influenzae or P. aeruginosa, each identified for the likely causative pathogen as the therapeutic target. The secondary endpoints were the proportion for the other commensal organisms and the proportion of the samples in which the HIRA-TAN could identify the therapeutic targets.
The study was performed between February 06, 2009 to October 14, 2010. 568 patients were enrolled and patients' characteristics were shown in Table 3 . The results of the microbiological examinations were summarized in Fig. 2 . The identification rates for H. influenzae and P. aeruginosa by the HIRA-TAN were 96.7% (29/30; 95% CI 82.8e99.2%) and 93.2% (41/44; 95% CI 81.3e97.5%) respectively (Fig. 3(A), (B) ). The response of the antibiotics and the relief of pneumonia for the cases in which H. influenzae or P. aeruginosa were the likely causative pathogens showed a consistent clinical course as predicted from the result of the HIRA-TAN. The identification rates for K. pneumoniae, M. catarrhalis, E. coli, MRSA and S. pneumoniae were as follows 80.6% (29/36; 95% CI 64.0e89.9%), 90.9% (10/11; 95% CI 58.7e97.7%), 87.5% (14/16; 95% CI 61.6e96.0%), 78.1% (25/32; 95% CI 60.0e88.5%) and 80.6% (87/108; 95% CI 71.8e86.8%) (Fig. 3(C)e(G) ).
Among 108 patients in which S. pneumoniae was the likely causative pathogen (Blue circles in Fig. 3(G)-1) , 39 patients were diagnosed by the positive UA test solely (enclosed Green and Orange circles in dashed rectangle in Fig. 3(G)-2 , which were a subpopulation of the S. pneumoniae pneumonia diagnosed by UA test solely). Out of these, 13 patients (Orange circles in Fig. 3(G)-2) showed no positive blood cultures and no suggestive grampositive diplococci on the Gram stain, no positive culture result and no detection by PCR for the S. pneumoniae in the purulent sputum (MJ classification M2 to P3 and Ct human of <27). This raises the possibility that in these cases the UA test was a false positive. Removing these potential false positives from our analysis results in an increase in the positive identifications for S. pneumonia to a rate of 91.6% (87/95; 95% CI 84.1e95.6% in Fig. 3(G)-2) .
Currently the ability of the HIRA-TAN system to determine if MRSA is the causative pathogen is lacking. This is due largely to the fact that for the determination and establishment of the cutoff value for a given microorganism in the HIRA-TAN system still requires the conventional sputum examination. To date we have not been able to determine the DCt MRSA cutoff and this will take more time and the availability of properly analyzed clinical samples to be established. Overall performance of HIRA-TAN system to identify both the therapeutic target (commensal organisms judged by the DCt cutoff) and the causative pathogen (foreign organisms detected by the real-time PCR) was altogether 60% en masse (Fig. 4) . The HIRA-TAN analysis was able to identify the therapeutic target in 60e70% of the samples (Fig. 4 or in the previous study [3] ), which is comparable to what is attained by an extensive search using multiple detection methods [4, 8, 14] .
Discussion
The most prominent feature of the HIRA-TAN is its ability to identify the causative pathogen for the pneumonias from among the commensal organisms detected in the sputum. Clinically, without this ability, this system would have been only partially useful, since more than half of pneumonias are caused by commensal organisms (Figs. 2  and 4 ). And this system does not require the use of pathogen-by-pathogen identification methods. The easily performed comprehensive test covers a wide variety of pathogens in a single assay, which will reduce the time and labor spent on cumbersome procedures. The HIRA-TAN procedure now provides a comprehensive detection system for causative pathogens of pneumonia.
The HIRA-TAN system can also be expanded to include more pathogens and thereby increasing its abilities. The addition of any respiratory viruses to the screening protocol is straightforward [4,5,15e18] . Likewise, the inclusion of commensal organisms, such as Acinetobacter baumannii or Stenotrophomonas maltophilia, will also be beneficial in the nosocomial pneumonia. Thus, the commensal organisms that have conformed to the scheme shown in Fig. 1 and all non-commensal organisms become candidates, which will make the greater detection rate by the HIRA-TAN than current 60e70% pertnqh_0009;formance.
S. aureus is frequently isolated commensal organism from respiratory samples, while is very often detected the long-term hospitalized patients. Thus it is difficult to establish a direct and causative role for this bacterium in pneumonia. Anaerobes as well, which are important commensal organisms for aspiration pneumonia or lung abscess, are also lacking the standard to be determined as causative pathogen. Since the cutoff value for commensal organisms in the HIRA-TAN system is based on the microbiological examination, is still incapable of being set up for the organisms which have not yet built the consensus for diagnosis. This should be addressed in future iterations of the HIRA-TAN procedure.
In conclusion, the HIRA-TAN approach yielded reproducible results and provided valuable information for planning the course of treatment of pneumonia. The current study established and validated the HIRA-TAN system. Through the rapid identification of the causative pathogens, the HIRA-TAN will promote targeted treatments for pneumonias. Figure 2 Etiology of pneumonia enrolled in the prospective study by conventional method. Description of isolates either a likely causative pathogen(s) (for the commensal organisms shown in orange) or a causative pathogen(s) (for the foreign organisms shown in green) *1 Mixed infection stands for the cases in which two or more pathogens were isolated among either likely causative pathogens or causative pathogens at one time. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Figure 3 DCt pathogen for each commensal organisms in the prospective study (n Z 568). Samples from patients with pneumonia in which a likely causative pathogen was identified using criteria (1)e(3) (see Materials and Methods) are shown as blue circles, and samples from patients with pneumonia in which none of criteria (1)e(3) was fulfilled were shown as white circles. The 30th case in which H. influenzae was a likely causative pathogen was enrolled on October 14, 2010, which terminated the prospective study. The HIRA-TAN identified the likely causative pathogens; (A) 96.7% for H. influenzae; (B) 93.2% for P. aeruginosa; (C) 80.6% for K. pneumoniae; (D) 90.9% for M. catarrhalis; (E) 87.5% for E. coli; (F) 78.1% for MRSA and (G) 91.6% for S. pneumoniae. The Blue circles in G-1 and G-2 showed the samples which S. pneumoniae was identified by blood cultures, sputum smears and cultures and/or UA test. Green and Orange circles in G-2, which were enclosed in dashed rectangle, were created subpopulation of the samples which S. pneumoniae was identified by UA test solely. Orange circles indicated no positive blood cultures, no suggestive gram-positive diplococcic on the Gram stain, no positive sputum culture and no detection by PCR for S. pneumoniae in the purulent sputum. The bottom two blue circles in F and the bottom 14 blue circles in G-1 were the likely causative pathogen for MRSA and S. pneumoniae, respectively, but not identified by real-time PCR. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Figure 4 Etiology of pneumonia enrolled in the prospective study by the HIRA-TAN system. Description of isolates either a therapeutic target(s) (for the commensal organisms shown in orange) or a causative pathogen(s) (for the foreign organisms shown in green) *1 Mixed infection stands for the case in which two or more pathogens were isolated among either therapeutic targets or causative pathogens at one time. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
